Exhibit 2.1
AGREEMENT AND PLAN OF
MERGER
BY AND AMONG
ON ASSIGNMENT, INC.,
ON ASSIGNMENT 2007 ACQUISITION
CORP.,
AND
OXFORD GLOBAL RESOURCES,
INC.
AND
THOMAS F. RYAN, AS
INDEMNIFICATION REPRESENTATIVE
JANUARY 3, 2007
TABLE OF CONTENTS
|
|
|
Page
|
|
|
|
|
ARTICLE I THE MERGER
|
1
|
|
|
|
|
1.1
|
The Merger
|
1
|
|
1.2
|
The Closing
|
1
|
|
1.3
|
Actions at the Closing
|
1
|
|
1.4
|
Additional Action
|
2
|
|
1.5
|
Conversion of Shares
|
2
|
|
1.6
|
Adjustments to Purchase Price
|
3
|
|
1.7
|
Dissenting Shares
|
5
|
|
1.8
|
Earnout
|
5
|
|
1.9
|
Escrow
|
8
|
|
1.10
|
Indemnification Representative
|
9
|
|
1.11
|
Currency
|
10
|
|
1.12
|
Certificate of Incorporation and
By-laws
|
10
|
|
1.13
|
No Further Rights
|
11
|
|
1.14
|
Closing of Transfer Books
|
11
|
|
1.15
|
Withholding
|
11
|
|
1.16
|
Fractional Shares
|
11
|
|
|
|
|
|
ARTICLE II REPRESENTATIONS AND WARRANTIES OF THE
COMPANY
|
11
|
|
|
|
|
2.1
|
Organization, Qualification and Corporate
Power
|
12
|
|
2.2
|
Capitalization
|
12
|
|
2.3
|
Authorization of Transaction
|
13
|
|
2.4
|
Noncontravention
|
14
|
|
2.5
|
Subsidiaries
|
14
|
|
2.6
|
Financial Statements
|
14
|
|
2.7
|
Absence of Certain Changes
|
14
|
|
2.8
|
Undisclosed Liabilities
|
14
|
|
2.9
|
Tax Matters
|
15
|
|
2.10
|
Assets
|
18
|
|
2.11
|
Owned Real Property
|
18
|
|
2.12
|
Real Property Leases
|
18
|
|
2.13
|
Intellectual Property
|
19
|
|
2.14
|
Contracts
|
20
|
|
2.15
|
Accounts Receivable
|
21
|
|
2.16
|
Powers of Attorney
|
21
|
|
2.17
|
Insurance
|
21
|
|
2.18
|
Litigation
|
22
|
|
2.19
|
Employees
|
22
|
|
2.20
|
Employee Benefits
|
23
|
|
2.21
|
Environmental Matters
|
26
|
|
2.22
|
Legal Compliance
|
26
|
i
|
2.23
|
Existing Customers and Suppliers
|
27
|
|
2.24
|
Permits
|
27
|
|
2.25
|
Certain Business Relationships With
Affiliates
|
27
|
|
2.26
|
Books and Records
|
27
|
|
2.27
|
Brokers’ Fees
|
27
|
|
2.28
|
Guarantees
|
27
|
|
2.29
|
Export and Industrial Security
|
27
|
|
2.30
|
Earnout and Contingent Payments
|
28
|
|
|
|
|
|
ARTICLE III REPRESENTATIONS AND WARRANTIES OF
THE BUYER AND THE TRANSITORY SUBSIDIARY
|
28
|
|
|
|
|
3.1
|
Organization and Corporate Power
|
28
|
|
3.2
|
Authorization of Transaction
|
28
|
|
3.3
|
Noncontravention
|
29
|
|
3.4
|
Litigation
|
29
|
|
3.5
|
Financing
|
29
|
|
3.6
|
Export and Industrial Security
|
29
|
|
3.7
|
Capitalization
|
30
|
|
3.8
|
Reports and Financial Statements
|
30
|
|
3.9
|
Solvency
|
30
|
|
|
|
|
|
ARTICLE IV COVENANTS
|
31
|
|
|
|
|
4.1
|
Closing Efforts
|
31
|
|
4.2
|
Governmental and Third-Party Notices and
Consents
|
31
|
|
4.3
|
Stockholder Approval
|
32
|
|
4.4
|
Operation of Business
|
32
|
|
4.5
|
Access to Information
|
34
|
|
4.6
|
Expenses
|
35
|
|
4.7
|
Director and Officer Indemnification
|
35
|
|
4.8
|
Repayment of Debt; Distribution of
Cash
|
36
|
|
4.9
|
Employment Matters
|
36
|
|
4.10
|
Stock Options
|
37
|
|
4.11
|
FIRPTA Tax Certificates
|
37
|
|
4.12
|
S Corporation Status
|
38
|
|
4.13
|
Withholding Forms
|
38
|
|
4.14
|
Export and Industrial Security
|
38
|
|
4.15
|
Registration of Stock Consideration
|
38
|
|
4.16
|
Notification
|
40
|
|
4.17
|
Tax Matters
|
40
|
|
4.18
|
Financial Statements
|
45
|
|
4.19
|
Real Property Leases
|
45
|
|
4.20
|
Company Unvested Stock Options
|
45
|
|
4.21
|
Financing
|
45
|
|
4.22
|
Letters of Credit
|
46
|
ii
|
ARTICLE V CONDITIONS TO CONSUMMATION OF
MERGER
|
46
|
|
|
|
|
5.1
|
Conditions to Each Party’s
Obligations
|
46
|
|
5.2
|
Conditions to Obligations of the Buyer and the
Transitory Subsidiary
|
46
|
|
5.3
|
Conditions to Obligations of the
Company
|
47
|
|
|
|
|
|
ARTICLE VI INDEMNIFICATION
|
48
|
|
|
|
|
6.1
|
Indemnification by the Company
Stockholders
|
48
|
|
6.2
|
Indemnification by the Buyer
|
49
|
|
6.3
|
Indemnification Claims
|
49
|
|
6.4
|
Survival of Representations and
Warranties
|
52
|
|
6.5
|
Limitations
|
53
|
|
6.6
|
Treatment of Indemnity Payments
|
54
|
|
|
|
|
|
ARTICLE VII TERMINATION
|
54
|
|
|
|
|
7.1
|
Termination of Agreement
|
54
|
|
7.2
|
Effect of Termination
|
55
|
|
|
|
|
|
ARTICLE VIII DEFINITIONS
|
56
|
|
|
|
|
ARTICLE IX MISCELLANEOUS
|
67
|
|
|
|
|
9.1
|
Press Releases and Announcements
|
67
|
|
9.2
|
No Third-Party Beneficiaries
|
67
|
|
9.3
|
Entire Agreement
|
67
|
|
9.4
|
Succession and Assignment
|
67
|
|
9.5
|
Counterparts and Facsimile Signature
|
67
|
|
9.6
|
Headings
|
68
|
|
9.7
|
Notices
|
68
|
|
9.8
|
Governing Law
|
68
|
|
9.9
|
Amendments and Waivers
|
69
|
|
9.10
|
Severability
|
69
|
|
9.11
|
Submission to Jurisdiction
|
69
|
|
9.12
|
Construction
|
69
|
|
9.13
|
Specific Performance
|
70
|
|
|
|
|
|
Exhibit A
|
Form of Promissory Note
|
|
|
Exhibit B
|
Allocation Schedule
|
|
|
Exhibit C
|
Form of Escrow Agreement
|
|
|
Exhibit D
|
Form of Lock-Up Agreement
|
|
|
Exhibit E-1
|
McGowan Employment Agreement
|
|
|
Exhibit E-2
|
McGowan Non-Competition Agreement
|
|
|
Exhibit F
|
Non-Competition Agreement
|
|
iii
AGREEMENT AND PLAN OF
MERGER
Agreement entered into as of January
3, 2007 by and among On Assignment, Inc., a Delaware corporation
(the “Buyer”), On Assignment 2007 Acquisition Corp., a
Delaware corporation and a wholly-owned subsidiary of the Buyer
(the “Transitory Subsidiary”), Oxford Global Resources,
Inc., a Delaware corporation (the “Company”) and Thomas
F. Ryan, as Indemnification Representative.
This Agreement contemplates a merger
of the Transitory Subsidiary into the Company. In such
merger, the stockholders of the Company (each, a “Company
Stockholder”) will receive cash and stock in exchange for
their capital stock of the Company.
In consideration of the
representations, warranties and covenants herein contained, the
Parties agree as follows.
ARTICLE I
THE MERGER
1.1
The
Merger . Upon and subject to
the terms and conditions of this Agreement, the Transitory
Subsidiary shall merge with and into the Company at the Effective
Time (the “Merger”). From and after the Effective
Time, the separate corporate existence of the Transitory Subsidiary
shall cease, and the Company shall continue as the Surviving
Corporation. The Merger shall have the effects set forth in
Section 259 of the Delaware General Corporation
Law.
1.2
The
Closing . The Closing shall
take place at the offices of Wilmer Cutler Pickering Hale and Dorr
LLP in Waltham, Massachusetts, commencing at 9:00 a.m. local
time on the Closing Date.
1.3
Actions at the
Closing . At the
Closing:
(a)
the Company shall
deliver to the Buyer and the Transitory Subsidiary the various
certificates, instruments and documents referred to in
Section 5.2;
(b)
the Buyer and the
Transitory Subsidiary shall deliver to the Company the various
certificates, instruments and documents referred to in
Section 5.3;
(c)
the Surviving
Corporation shall file with the Secretary of State of the State of
Delaware the Certificate of Merger;
(d)
each Company
Stockholder shall deliver to the Buyer for cancellation the
certificate(s) representing his/her shares of Common Stock, $.01
par value per share, of the Company (the “Company
Shares”);
(e)
the Buyer shall
pay to each Company Stockholder the Per Share Cash Consideration
and the Per Share Stock Consideration into which his or her Company
Shares are converted pursuant to Section 1.5 by delivery of a
promissory note in the form attached hereto as
Exhibit A , which note shall be backed by a standby
letter of credit issued by a bank mutually
1
acceptable to the
Buyer and the Company, the costs of which shall be paid at Closing
by the Company Stockholders, and which may be repaid by delivery to
each Company Stockholder of the Per Share Cash Consideration and
the Per Share Stock Consideration into which his or her Company
Shares are converted pursuant to Section 1.5;
(f)
the Buyer shall
deliver the aggregate Per Share Option Consideration to the
Company, which shall pay by check or by wire transfer to each
Optionholder the Per Share Option Consideration into which his or
her Options are converted pursuant to Section 1.5; and
(g)
the Buyer, the
Indemnification Representative and the Escrow Agent shall execute
and deliver the Escrow Agreement, and the Buyer or the Transitory
Subsidiary shall deposit an amount in cash equal to $20,000,000
(the “Escrow Cash”) with the Escrow Agent in accordance
with Section 1.9.
1.4
Additional
Action . The Surviving
Corporation may, at any time after the Effective Time, take any
action, including executing and delivering any document, in the
name and on behalf of either the Company or the Transitory
Subsidiary, in order to consummate the transactions contemplated by
this Agreement.
1.5
Conversion of
Shares . At the Effective
Time, by virtue of the Merger and without any action on the part of
any Party or the holder of any of the following
securities:
(a)
Capital Stock
of Transitory Subsidiary . Each share of common
stock of the Transitory Subsidiary issued and outstanding
immediately prior to the Effective Time shall be converted into and
thereafter evidence one share of common stock, $.01 par value per
share, of the Surviving Corporation.
(b)
Treasury
Stock . Each Company Share
held in the Company’s treasury immediately prior to the
Effective Time and each Company Share owned beneficially by the
Buyer or the Transitory Subsidiary immediately prior to the
Effective Time shall be cancelled and retired without payment of
any consideration therefor.
(c)
Merger
Consideration; Conversion of Equity . The aggregate merger
consideration to be paid by the Buyer at the Closing in respect of
all of the outstanding shares of capital stock of the Company and
all of the outstanding Company Vested Stock Options shall be (i)
One Hundred Ninety Million Dollars ($190,000,000) (the “Cash
Consideration”) and (ii) a number of shares of Buyer Common
Stock with a value of $10,000,000, based on the Buyer Common Stock
Price (the “Stock Consideration”) (the amount of the
Cash Consideration and the Stock Consideration collectively, the
“Purchase Price”), subject to adjustment pursuant to
Section 1.6 hereof. The Stock Consideration may be paid
in any combination of cash and/or Buyer Common Stock at the sole
option of Buyer; provided that if Buyer chooses to pay all or a
portion of the Stock Consideration in cash, the amount shall equal
the greater of (i) the value of the shares of Buyer Common
Stock not delivered based on the Buyer Common Stock Price and
(ii) the value of the shares of Buyer Common Stock not
delivered based on the closing price of the Buyer Common Stock on
the trading day prior to the Closing Date. At the
Closing:
2
(i)
each Company
Share issued and outstanding immediately prior to the Effective
Time (other than Company Shares owned beneficially by the Buyer or
the Transitory Subsidiary, Dissenting Shares and Company Shares
held in the Company’s treasury) shall be converted into and
represent the right to receive, (A) the Per Share Cash
Consideration, (B) the Per Share Stock Consideration,
(C) the Per Share 2007 Stockholder Earnout Amount and
(D) the Per Share 2008 Earnout Amount, without any interest
thereon;
(ii)
each Company
Vested Stock Option issued and outstanding immediately prior to the
Effective Time shall be converted into and represent the right to
receive, in cash, (A) the excess of (1) the Per Share Option
Consideration less (2) the exercise price per share of the
Company Shares subject to such Company Vested Stock Option, (B) the
Per Share 2007 Optionholder Earnout Amount and (C) the Per
Share 2008 Earnout Amount, without any interest thereon;
and
(iii)
each Company
Unvested Stock Option shall be cancelled without payment of
consideration therefor.
1.6
Adjustments to
Purchase Price .
(a)
Closing Date
Purchase Price Adjustment .
(i)
Not later than
three Business Days prior to the Closing Date, the Company shall
provide the Buyer with an estimated balance sheet of the Company as
of the close of business on the Closing Date (the “Estimated
Closing Balance Sheet”) and a statement of the estimated
Closing Working Capital derived from the Estimated Closing Balance
Sheet (“Estimated Closing Working Capital”). The
Estimated Closing Balance Sheet shall be prepared by the Company in
accordance with GAAP and the Estimated Closing Working Capital
shall be prepared by the Company in accordance with
Schedule 1.6(a) attached hereto.
(ii)
If Estimated
Closing Working Capital is less than Target Working Capital, then
the Cash Consideration payable at Closing will be decreased by the
positive difference between Estimated Closing Working Capital and
Target Working Capital (the “Estimated Closing Working
Capital Shortfall”). If Estimated Closing Working
Capital is greater than Target Working Capital, then the Cash
Consideration payable at Closing will be increased by the positive
difference between Estimated Closing Working Capital and Target
Working Capital (the “Estimated Closing Working Capital
Excess”). “Target Working Capital” shall be
$13,198,055.
(b)
Post-Closing
Date Purchase Price Adjustment .
(i)
Following the
Closing, the Purchase Price shall be adjusted as provided herein to
reflect the difference between Closing Working Capital and
Estimated Closing Working Capital.
(ii)
Within 60 days
following the Closing Date, the Buyer shall deliver to the
Indemnification Representative a balance sheet of the Company as of
the close of business on the Closing Date (the “Closing
Balance Sheet”), reviewed by the Company’s
independent
3
accountants, and
a statement of Closing Working Capital derived from the Closing
Balance Sheet (the “Closing Working Capital
Statement”). The Closing Balance Sheet shall be
prepared in accordance with GAAP and the Closing Working Capital
Statement shall be prepared in accordance with Schedule 1.6(a)
attached hereto. The Surviving Corporation shall cooperate
with the Buyer in connection with the preparation of the Closing
Balance Sheet and Closing Working Capital Statement. The
Surviving Corporation shall assist the Indemnification
Representative with his review of the Closing Balance Sheet and the
Closing Working Capital Statement and all financial statements and
work papers related thereto. The Indemnification
Representative shall have reasonable access to the books and
records (including financial statements and work papers) of the
Surviving Corporation during regular business hours for the purpose
of verifying the Closing Balance Sheet and the Closing Working
Capital Statement.
(iii)
The Closing
Balance Sheet and the Closing Working Capital Statement (and the
computation of Closing Working Capital indicated thereon) delivered
to the Indemnification Representative by the Buyer shall be
conclusive and binding upon the parties unless the Indemnification
Representative, within 30 days after delivery to the
Indemnification Representative of the Closing Balance Sheet and the
Closing Working Capital Statement, notifies the Buyer in writing
that the Indemnification Representative disputes any of the amounts
set forth therein, specifying in detail the nature of the dispute
and the basis therefor. The parties shall in good faith
attempt to resolve any dispute and, if the parties so resolve all
disputes, the Closing Balance Sheet and the Closing Working Capital
Statement (and the computation of Closing Working Capital indicated
thereon), as amended to the extent necessary to reflect the
resolution of the dispute, shall be conclusive and binding on the
parties. If the parties do not reach agreement in resolving
the dispute within 30 days after notice is given by the
Indemnification Representative to the Buyer pursuant to the second
preceding sentence, the parties shall submit the dispute to a
nationally recognized independent accounting firm which is mutually
agreeable to the parties (the “Arbiter”) for
resolution. If the parties cannot agree on the selection of
an independent accounting firm to act as Arbiter, the parties shall
request the American Arbitration Association to appoint such firm,
and such appointment shall be conclusive and binding on the
parties. Promptly, but no later than 20 days after acceptance
of his or her appointment as Arbiter, the Arbiter shall determine
(it being understood that in making such determination, the Arbiter
shall be functioning as an expert and not as an arbitrator), based
solely on written submissions by the Buyer and the Indemnification
Representative, and not by independent review, only those issues in
dispute and shall render a written report as to the resolution of
the dispute and the resulting computation of the Closing Working
Capital which shall be conclusive and binding on the parties.
All proceedings conducted by the Arbiter shall take place in
Boston, Massachusetts. In resolving any disputed item, the
Arbiter (x) shall be bound by the provisions of this
Section 1.6 and (y) may not assign a value to any item
greater than the greatest value for such items claimed by either
party or less than the smallest value for such items claimed by
either party. The fees, costs and expenses of the Arbiter
shall be equally allocated to and borne by the Buyer and the
Company Stockholders.
(iv)
Upon final
determination of Closing Working Capital as provided in
Section 1.6(b)(iii) above, (A) if Closing Working Capital
is greater than Estimated Closing Working Capital, the Cash
Consideration shall be increased by the excess of Closing Working
Capital over Estimated Closing Working Capital (the “Working
Capital Excess”), and the Buyer
4
shall promptly,
but no later than five business days after such final
determination, pay the Additional Cash Per Share to the Company
Stockholders and Optionholders (by check or by wire transfer of
immediately available funds to accounts previously designated by
each Company Stockholder and each Optionholder), and (B) if
Closing Working Capital is less than Estimated Closing Working
Capital, the Cash Consideration shall be decreased by the excess of
Estimated Closing Working Capital over Closing Working Capital, and
the Company Stockholders shall pay to the Buyer the amount of such
difference, (the “Working Capital
Shortfall”).
(v)
If an amount is
payable to the Buyer pursuant to Section 1.6(b)(iv), such
amount shall be paid to the Buyer within five business days after a
final determination by the Company Stockholders, jointly and
severally, in cash, by cashier’s or certified check or by
wire transfer of immediately available funds to an account
designated by the Buyer within such period. If the amount is
not paid by the Company Stockholders within such period, (i) such
amount shall be paid by the Escrow Agent from the Escrow Cash and
any earnout payment due pursuant to Section 1.8 shall be paid to
the Escrow Agent as Escrow Cash to the extent of such payment (less
amounts paid by the Company Stockholders to the Escrow Agent as
Escrow Cash) and (ii) such amount shall remain due and payable by
the Company Stockholders to the Escrow Agent as Escrow
Cash.
1.7
Dissenting
Shares .
(a)
Dissenting Shares
shall not be converted into or represent the right to receive the
Merger Consideration unless the Company Stockholder holding such
Dissenting Shares shall have forfeited his, her or its right to
appraisal under the Delaware General Corporation Law or properly
withdrawn his, her or its demand for appraisal. If such
Company Stockholder has so forfeited or withdrawn his, her or its
right to appraisal of Dissenting Shares, then, (i) as of the
occurrence of such event, such holder’s Dissenting Shares
shall cease to be Dissenting Shares and shall be converted into and
represent the right to receive the Merger Consideration payable in
respect of such Company Shares pursuant to Section 1.5, and
(ii) promptly following the occurrence of such event, the
Buyer or the Surviving Corporation shall deliver to such Company
Stockholder a payment representing the portion of the Merger
Consideration to which such holder is entitled pursuant to
Section 1.5.
(b)
The Company shall
give the Buyer (i) prompt notice of any written demands for
appraisal of any Company Shares, withdrawals of such demands, and
any other instruments that relate to such demands received by the
Company and (ii) the opportunity to direct all negotiations
and proceedings with respect to demands for appraisal under the
Delaware General Corporation Law. The Company shall not,
except with the prior written consent of the Buyer, make any
payment with respect to any demands for appraisal of Company Shares
or offer to settle or settle any such demands.
1.8
Earnout
.
(a)
Earnout
Payment . In addition to the
consideration payable and/or issuable to the Company Stockholders
and Optionholders pursuant to Sections 1.5 and 1.6 hereof, the
Company Stockholders shall be entitled to
5
receive the Per
Share 2007 Stockholder Earnout Amount and the Per Share 2008
Earnout Amount and the Optionholders shall be entitled to receive
the Per Share 2007 Optionholder Earnout Amount and the Per Share
2008 Earnout Amount multiplied by the number of shares held by each
Company Stockholder and underlying the Company Vested Stock Options
held by each Optionholder as applicable.
(b)
Time for
Determination .
(i)
Within 10 days
following the completion of the audited financial statements of
Buyer for each of the Earnout Periods, Buyer shall determine the
Earnout EBITDA for such Earnout Period (the “Applicable
Earnout EBITDA”) and deliver to the Indemnification
Representative a copy of such computation. Upon the request
of the Indemnification Representative, the Buyer shall prepare and
deliver to the Indemnification Representative income statement and
expense detail supporting the calculation of the Applicable Earnout
EBITDA for such Earnout Period. Such computation delivered to
the Indemnification Representative by the Buyer shall be conclusive
and binding upon the parties, unless the Indemnification
Representative, within 30 days after delivery to the
Indemnification Representative of such computation, notifies the
Buyer in writing that the Indemnification Representative disputes
any of the amounts set forth therein, specifying the nature of the
dispute and the basis therefor. Immediately following
delivery of the computation of the Applicable Earnout EBITDA, the
Indemnification Representative shall have reasonable access to the
books and records (including financial statements) of the Surviving
Corporation during regular business hours for the purpose of
verifying Buyer’s computation of the Applicable Earnout
EBITDA and the Applicable Earnout Amount for such Earnout
Period. Solely for the purpose of clarification, the 2007
Earnout Amount and the 2008 Earnout Amount A will be computed after
the completion of the audited financial statements of Buyer for its
fiscal year ending December 31, 2007 and the 2008 Earnout Amount B
shall be computed after the completion of the audited financial
statements of Buyer for its fiscal year ending December 31,
2008.
(ii)
The parties shall
in good faith attempt to resolve any dispute and, if the parties so
resolve all disputes, the computation of the Applicable Earnout
EBITDA, as amended to the extent necessary to reflect the
resolution of the dispute, shall be conclusive and binding on the
parties. If the parties do not reach agreement in resolving
the dispute within 30 days after notice is given by the
Indemnification Representative to the Buyer pursuant to Section
1.8(b)(i) above, the parties shall submit the dispute to a
nationally recognized independent accounting firm which is mutually
agreeable to the parties (the “Earnout Arbiter”) for
resolution. If the parties cannot agree on the selection of
an independent accounting firm to act as the Earnout Arbiter, the
parties shall request the American Arbitration Association to
appoint such firm, and such appointment shall be conclusive and
binding on the parties. Promptly, but no later than 20 days
after acceptance of his or her appointment as Earnout Arbiter, the
Earnout Arbiter shall determine (it being understood that in making
such determination, the Earnout Arbiter shall be functioning as an
expert and not as an arbitrator), based solely on written
submissions by the Buyer and the Indemnification Representative,
and not by independent review, only those issues in dispute and
shall render a written report as to the resolution of the dispute
and the resulting computation of the Applicable Earnout Amount,
which shall be conclusive and binding on the parties. All
proceedings conducted by the Earnout Arbiter shall take place in
Boston, Massachusetts. In resolving any disputed item, the
Earnout Arbiter (x) shall be bound by the provisions of this
Section 1.8(b)(ii) and (y) may not assign a value
to
6
the Applicable
Earnout Amount greater than the greatest value for such item
claimed by either party or less than the smallest value for such
item claimed by either party. The fees, costs and expenses of
the Earnout Arbiter shall be equally allocated to and borne by the
Buyer and the Company Stockholders.
(iii)
The Applicable
Earnout Amount shall be paid to the Company Stockholders and the
Optionholders as follows: (A) as to any amounts that are not
subject to dispute as set forth in a notice of the Indemnification
Representative pursuant to Section 1.8(b)(ii) above, within a
reasonable time after the expiration of the time during which the
Indemnification Representative may object to the Buyer’s
calculation of the Applicable Earnout Amount; and (B) as to any
amounts that are subject to dispute as set forth in a notice of the
Indemnification Representative pursuant to Section 1.8(b)(ii)
above, within five (5) business days following the date that the
determination of the disputed portion of the Applicable Earnout
Amount shall become binding and conclusive in accordance with
Sections 1.8(b)(i) or 1.8(b)(ii) above, as the case may
be.
(c)
Operation of
Surviving Corporation . During the Earnout
Period, the Surviving Corporation shall be operated (i) in a
commercially reasonable manner that balances the short-term
earnings and long-term growth of the Company; (ii) in a manner
reasonably similar to its operations in 2006 and
(iii) consistent with the assumptions underlying the
projections prepared by the Company for the Earnout Period.
In particular:
(i)
The Surviving
Corporation shall be maintained and accounted for as a
free-standing subsidiary of the Buyer and not combined with any
other current or future business operations of Buyer or its other
subsidiaries.
(ii)
The business and
affairs of the Surviving Corporation shall be managed by or under
the direction of Michael McGowan (or, if Michael McGowan ceases to
be employed by the Surviving Corporation during 2007, such other
person appointed by Buyer following good faith consultation with
the Indemnification Representative), who shall (i) report
directly to the Chief Executive Officer of the Buyer and
(ii) have authority and discretion to run and operate the
business of the Surviving Corporation in a manner consistent with
the operation of the business of the Company during the 12-month
period prior to the Closing, including making strategic and
operating decisions affecting the business and affairs of the
Surviving Corporation.
(iii)
The Buyer shall
not take any action that will materially increase the SG&A
expenses of the Surviving Corporation in the aggregate without the
prior written consent of the President of the Surviving
Corporation, which consent shall not be unreasonably
withheld. Notwithstanding the previous sentence, no consent
will be required if an appropriate adjustment is made to negate the
impact of such expense on the Applicable Earnout EBITDA. For
purposes of this Section 1.8, “material” shall mean any
amount in excess of $250,000.
(iv)
To the extent
that the Buyer requires the Surviving Corporation to incur
additional SG&A expenses that in the aggregate are material and
it would not otherwise incur, an increase shall be made to the
Applicable Earnout EBITDA equal to the amount of such amount in
excess of $250,000. To the extent that the Buyer requires the
Surviving Corporation
7
to incur
additional SG&A expenses unrelated to the Company’s
business, an increase shall be made to the Applicable Earnout
EBITDA. For purposes of clarification only, it would be
unrelated to the Company’s business if, at the request of the
Buyer, the Surviving Corporation adds to its staff accountants or
implements information technology systems to assist other
subsidiaries of the Buyer.
(d)
Accounting
. In
calculating the EBITDA of the Surviving Corporation for purposes of
this Agreement, the operations of the Surviving Corporation shall
be accounted for in accordance with GAAP as in effect on the
Closing Date, applied consistently with the Company’s
existing (as of the Closing Date) accounting practices and
procedures, except to the extent that any of such accounting
practices and procedures are not in compliance with GAAP as in
effect on the Closing Date. Any subsequent changes in GAAP
that would materially affect EBITDA shall not be taken into account
for purposes of calculating EBITDA for purposes of this Agreement
(regardless of how accounted for other purposes such as the
Buyer’s SEC reporting or internal accounting).
(e)
Acceleration
.
Notwithstanding any other provision of this Agreement, in the event
that at any point prior to the end of the Earnout Period the Buyer
or any Affiliate or successor entity of the Buyer ceases to be
(either directly, or indirectly through one or more wholly owned
subsidiaries) the owner of all of the outstanding capital stock of
or other equity interests in the Surviving Corporation, then
immediately upon the occurrence of any such event, the Buyer shall
irrevocably become liable to pay, to the extent then unpaid, to the
Company Stockholders and the Optionholders the maximum 2007 Earnout
Amount, 2008 Earnout Amount A and 2008 Earnout Amount B (if such
event occurs in 2007) and the applicable 2007 Earnout Amount and
the maximum 2008 Earnout Amount (if such event occurs in
2008). Such 2007 Earnout Amount and the 2008 Earnout Amount
shall be delivered by the Buyer by check or wire transfer of
immediately available funds to the accounts previously designated
by the Company Stockholders and the Optionholders.
(f)
Acknowledgement.
The Buyer
and the Company acknowledge: (i) the payment of the Applicable
Earnout Amount hereunder is an integral part of the consideration
to be received by the Company Stockholders and Optionholders
pursuant to this Agreement and the transactions contemplated
hereby; (ii) the Applicable Earnout Amount is not dependent upon
the operating results of Buyer or any subsidiary or affiliate of
Buyer; (iii) the right of the Company Stockholders and
Optionholders to a portion of the Applicable Earnout Amount is not
transferable other than by operation of law or as otherwise
provided herein; (iv) the right of the Company Stockholders and
Optionholders to a portion of the Applicable Earnout Amount shall
not be represented by a certificate or other instrument, shall not
represent an ownership interest in Buyer and shall not entitle any
Company Stockholders or Optionholders to any rights common to any
holder of Buyer Common Stock; and (v) the right of the Company
Stockholders and Optionholders to payment of the Applicable Earnout
Amount shall not bear any interest except to the extent the payment
thereof by the Buyer is delayed in violation of this
Agreement.
1.9
Escrow
.
(a)
On the Closing
Date, the Buyer or the Transitory Subsidiary shall deposit the
Escrow Cash with the Escrow Agent for the purpose of securing the
indemnification
8
obligations of
the Company Stockholders set forth in this Agreement. The
Escrow Cash shall be held by the Escrow Agent under the Escrow
Agreement pursuant to the terms thereof until the date that is
18 months following the Closing Date (the “Escrow
Termination Date”). The Escrow Cash shall be held as a
trust fund and shall not be subject to any lien, attachment,
trustee process or any other judicial process of any creditor of
any party, and shall be held and disbursed solely for the purposes
and in accordance with the terms of the Escrow
Agreement.
(b)
The adoption of
this Agreement and the approval of the Merger by the Company
Stockholders shall constitute approval of the Escrow Agreement and
of all of the arrangements relating thereto, including the
placement of the Escrow Cash in escrow.
1.10
Indemnification
Representative .
(a)
The Company
Stockholders by the approval and adoption of this Agreement
appoint, authorize and empower Thomas F. Ryan (the
“Indemnification Representative”) to act on behalf of
each Company Stockholder in connection with, and to facilitate the
consummation of the transactions under, this Agreement, which shall
include the power and authority (i) to make all decisions
relating to the determination of any adjustments to the Cash
Consideration and the determination of the Applicable Earnout
EBITDA, (ii) to take all action necessary in connection with
the defense and/or settlement of any claims for which the Company
Stockholders may be required to indemnify the Buyer pursuant to
Article VI hereof, (iii) to give and receive all notices
required to be given under the Agreement, (iv) to execute and
deliver the Escrow Agreement, (v) to execute and deliver such
amendments to this Agreement as the Indemnification Representative,
in his reasonable discretion, may deem necessary or desirable to
give effect to the intentions of this Agreement, and (vi) to
take any and all additional action as is contemplated to be taken
by or on behalf of the Company Stockholders by the terms of this
Agreement.
(b)
In the event of
the death or permanent disability of the Indemnification
Representative, Adam Ryan shall serve as Indemnification
Representative. In the event of the death or permanent
disability of Adam Ryan, a successor Indemnification Representative
shall be elected by a majority vote of the Company Stockholders,
with each such Company Stockholder (or his, her or its successors
or assigns) to be given a vote equal to the number of votes
represented by the shares of stock of the Company held by such
Company Stockholder immediately prior to the effective time of the
Merger. Each successor Indemnification Representative shall
have all of the power, authority, rights and privileges conferred
by this Agreement and the Escrow Agreement upon the original
Indemnification Representatives.
(c)
All decisions and
actions by the Indemnification Representative, including, without
limitation, any agreement between the Indemnification
Representative and the Buyer relating to the determination of any
adjustments to the Cash Consideration and the determination of the
Applicable Earnout EBITDA, the defense or settlement of any claims
for which the Company Stockholders may be required to indemnify the
Buyer pursuant to Article VI hereof or the amendment of this
Agreement shall be binding upon all of the Company Stockholders,
and no Company Stockholder shall have the right to object, dissent,
protest or otherwise contest the same.
9
(d)
By their adoption
and approval of this Agreement, the Company Stockholders agree
that:
(i)
the Buyer shall
be able to rely conclusively on the instructions and decisions of
the Indemnification Representative as to the determination of any
adjustments to the Cash Consideration and the determination of the
Applicable Earnout EBITDA, the settlement of any claims for
indemnification by the Buyer pursuant to Article VI hereof, the
amendment of this Agreement or any other actions required to be
taken by the Indemnification Representative hereunder, and no Party
hereunder shall have any cause of action against the Buyer or the
Indemnification Representative for any action taken by the Buyer in
reliance upon the instructions or decisions of the Indemnification
Representative;
(ii)
all actions,
decisions and instructions of the Indemnification Representative
shall be conclusive and binding upon all of the Company
Stockholders, and no Company Stockholder shall have any cause of
action against the Indemnification Representative for any action
taken, decision made or instruction given by the Indemnification
Representative under this Agreement, except for fraud or willful
breach of this Agreement by the Indemnification
Representative;
(iii)
the provisions of
this Section 1.10 are independent and severable, are irrevocable
and coupled with an interest and shall be enforceable
notwithstanding any rights or remedies that any Company Stockholder
may have in connection with the transactions contemplated by this
Agreement;
(iv)
remedies
available at law for any breach of the provisions of this
Section 1.10 are inadequate; therefore, the Buyer, the
Indemnification Representative and the Company shall be entitled to
temporary and permanent injunctive relief without the necessity of
proving damages if any such Party brings an action to enforce the
provisions of this Section 1.10; and
(v)
the provisions of
this Section 1.10 shall be binding upon the executors, heirs, legal
representatives and successors of each Company Stockholder, and any
references in this Agreement to a Company Stockholder or the
Company Stockholders shall mean and include the successors to the
Company Stockholders’ rights hereunder, whether pursuant to
testamentary disposition, the laws of descent and distribution or
otherwise.
(e)
All fees and
expenses incurred by the Indemnification Representative shall be
paid by the Company Stockholders in proportion to their ownership
of Company Shares.
1.11
Currency
. All
references herein to “Dollars” and amounts preceded by
a “$” shall be construed as references to United States
dollars.
1.12
Certificate of
Incorporation and By-laws .
(a)
The Certificate
of Incorporation of the Surviving Corporation immediately following
the Effective Time shall be amended and restated in its entirety so
that such Certificate of Incorporation is identical to the
Certificate of Incorporation of the Transitory
Subsidiary
10
immediately prior
to the Effective Time, except that (i) the name of the
corporation set forth therein shall be changed to the name of the
Company and (ii) the identity of the incorporator shall be
deleted.
(b)
The By-laws of
the Surviving Corporation immediately following the Effective Time
shall be the same as the By-laws of the Transitory Subsidiary
immediately prior to the Effective Time, except that the name of
the corporation set forth therein shall be changed to the name of
the Company.
1.13
No Further
Rights . From and after the
Effective Time, no Company Shares shall be deemed to be
outstanding, and holders of certificates formerly representing
Company Shares shall cease to have any rights with respect thereto
except as provided herein or by law.
1.14
Closing of
Transfer Books . At the Effective
Time, the stock transfer books of the Company shall be closed and
no transfer of Company Shares shall thereafter be made. If,
after the Effective Time, certificates formerly representing
Company Shares are presented to the Buyer or the Surviving
Corporation, they shall be cancelled and exchanged for the Merger
Consideration in accordance with Section 1.5, subject to
applicable law in the case of Dissenting Shares.
1.15
Withholding
. The Buyer
shall be entitled to deduct and withhold from the consideration
otherwise payable pursuant to this Agreement to any Company
Stockholder and any Optionholder such amounts as the Buyer is
required to deduct and withhold under the Code, or any Tax
provision, with respect to the making of such payment. To the
extent that amounts are so withheld by the Buyer, such withheld
amounts shall be treated for all purposes of this Agreement as
having been paid to the Company Stockholders or Optionholders, as
applicable, in respect of whom such deduction and withholding was
made by the Buyer.
1.16
Fractional
Shares . No certificate or
scrip representing fractional shares of Buyer Common Stock shall be
issued upon the surrender for exchange of the Company Shares, and
such fractional share interests will not entitle the owner thereof
to vote or to any rights as a stockholder of the Buyer.
Notwithstanding any other provision of this Agreement, each holder
of Company Shares as of the Closing Date who would otherwise have
been entitled to receive a fraction of a share of Buyer Common
Stock shall receive, in lieu thereof, cash (without interest) in an
amount equal to such fractional part of a share of Buyer Common
Stock multiplied by the Buyer Common Stock Price.
ARTICLE II
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
The Company represents and warrants
to the Buyer that, except as set forth in the Disclosure Schedule,
the statements contained in this Article II are true, correct
and complete as of the date of this Agreement and will be true,
correct and complete as of the Closing as though made as of the
Closing, except to the extent such representations and warranties
are specifically made as of a particular date (in which case such
representations and warranties will be true and correct as of such
date). The Disclosure Schedule shall be arranged in sections
and subsections corresponding to the numbered and lettered sections
and subsections contained in this Article II.
11
The disclosures in any section or
subsection of the Disclosure Schedule shall qualify other sections
and subsections in this Article II to the extent it is reasonably
clear from a reading of the disclosure that such disclosure is
applicable to such other sections and subsections. For
purposes of this Article II, the phrase “to the knowledge of
the Company” or “of which the Company is aware”
or any variation of any of the foregoing or phrase of similar
import shall be deemed to refer to the actual knowledge of
Thomas F. Ryan, Michael McGowan, Edward Kelly and Robert
Indresano.
2.1
Organization,
Qualification and Corporate Power . The Company is a
corporation duly organized, validly existing and in corporate good
standing under the laws of the State of Delaware. The Company
is duly qualified to conduct business and is in corporate and tax
good standing under the laws of each jurisdiction listed in Section
2.1 of the Disclosure Schedule, which jurisdictions constitute the
only jurisdictions in which the nature of the Company’s
business or the ownership or leasing of its real properties
requires such qualification. The Company has all requisite
corporate power and authority to carry on the business in which it
is engaged and to own and use the properties owned and used by
it. The Company has furnished to the Buyer complete and
accurate copies of its certificate of incorporation and
by-laws. The Company is not in default under or in violation
of any provision of its certificate of incorporation or
by-laws.
2.2
Capitalization
.
(a)
The authorized
capital stock of the Company consists of 20,000,000 Company Shares,
of which 13,150,000 shares are issued and outstanding.
(b)
Section 2.2 of
the Disclosure Schedule sets forth a complete and accurate list, as
of the date of this Agreement, of the holders of capital stock of
the Company, showing the number of shares of such capital stock
held by each Stockholder. Section 2.2 of the Disclosure
Schedule also indicates any outstanding Company Shares that
constitute restricted stock or that are otherwise subject to a
repurchase or redemption right, indicating the name of the
applicable Stockholder, the vesting schedule (including any
acceleration provisions with respect thereto), and the repurchase
price payable by the Company. All of the issued and
outstanding shares of capital stock of the Company have been duly
authorized and validly issued and are fully paid and
nonassessable. All of the issued and outstanding shares of
capital stock of the Company have been offered, issued and sold by
the Company in compliance with all applicable federal and state
securities laws.
(c)
Section 2.2(c) of
the Disclosure Schedule sets forth a complete and accurate list, as
of the date of this Agreement of: (i) all Company Stock Plans,
indicating for each Company Stock Plan the number of Company Shares
issued to date under such Plan, the number of Company Shares
subject to outstanding Options under such Plan and the number of
Company Shares reserved for future issuance under such Plan; and
(ii) all holders of outstanding Options, indicating with respect to
each Option the Company Stock Plan under which it was granted, the
number of Company Shares subject to such Option, the exercise
price, the date of grant, and the vesting schedule (including any
acceleration provisions with respect thereto). The Company
has provided to the Buyer complete and accurate copies of all
Company Stock Plans and forms of all stock option agreements
evidencing Options. All Options have been granted in
compliance in all
12
material respects
with applicable law and the terms of the applicable Company Stock
Plans and, to the knowledge of the Company, have (or with respect
to such Options which have been exercised as of the date of this
Agreement, had) a per share exercise price that is (or with respect
to such Options which have been exercised as of the date of this
Agreement, was) at least equal to the fair market value of a share
of the underlying stock as of the date the Option was granted
(determined in accordance with applicable law, including, to the
extent applicable, Code Section 409A). The Company has (i)
1,374,900 shares available for issuance under the Company’s
Amended and Restated 2001 Share Incentive Plan, and (ii) 27,700
shares available for issuance under the Company’s Amended and
Restated 2004 California Share Incentive Plan, which available
shares, in each case, exclude all shares subject to any Options
(together, the “ Available Shares
”).
(d)
Except as set
forth in this Section 2.2 or in Section 2.2 of the Disclosure
Schedule, (i) no subscription, warrant, option, convertible
security or other right (contingent or otherwise) to purchase or
acquire any shares of capital stock of the Company is authorized or
outstanding, (ii) the Company has no obligation (contingent or
otherwise) to issue any subscription, warrant, option, convertible
security or other such right, or to issue or distribute to holders
of any shares of its capital stock any evidences of indebtedness or
assets of the Company, (iii) the Company has no obligation
(contingent or otherwise) to purchase, redeem or otherwise acquire
any shares of its capital stock or any interest therein or to pay
any dividend or to make any other distribution in respect thereof,
and (iv) there are no outstanding or authorized stock appreciation,
phantom stock, restricted stock, profit participation or other
rights based on or measured by the value of any equity security of,
or interest in, the Company.
(e)
There is no
agreement, written or oral, between the Company and any holder of
its securities, or, to the Company’s knowledge, among any
holders of its securities, relating to the sale or transfer
(including agreements relating to rights of first refusal, co-sale
rights or “drag-along” rights), registration under the
Securities Act, or voting, of the capital stock of the
Company.
2.3
Authorization
of Transaction . The Company has all
requisite power and authority to execute and deliver this Agreement
and all other agreements contemplated hereby to which it is a party
and to perform its obligations hereunder and thereunder. The
execution and delivery by the Company of this Agreement and all
other agreements contemplated hereby to which it is a party, and,
subject to obtaining the Requisite Stockholder Approval, which is
the only approval required from the Company Stockholders, the
consummation by the Company of the transactions contemplated hereby
and thereby have been duly and validly authorized by all necessary
corporate action on the part of the Company. Without limiting
the generality of the foregoing, the Board of Directors of the
Company, at a meeting duly called and held, by the unanimous vote
of all directors (i) determined that the Merger is advisable,
fair and in the best interests of the Company and its stockholders,
(ii) adopted this Agreement in accordance with the provisions
of the Delaware General Corporation Law, and (iii) directed
that this Agreement and the Merger be submitted to the stockholders
of the Company for their adoption and approval and resolved to
recommend that the stockholders of the Company vote in favor of the
adoption of this Agreement and the approval of the Merger.
This Agreement and all other agreements contemplated hereby to
which it is a party have been duly and validly executed and
delivered by
13
the Company and
constitutes a valid and binding obligation of the Company,
enforceable against the Company in accordance with its
terms.
2.4
Noncontravention
. Subject
to compliance with the applicable requirements of the
Hart-Scott-Rodino Act and the filing of the Certificate of Merger
as required by the Delaware General Corporation Law, neither the
execution and delivery by the Company of this Agreement, nor the
consummation by the Company of the transactions contemplated
hereby, will (a) conflict with or violate any provision of the
certificate of incorporation or by-laws of the Company,
(b) require on the part of the Company any notice to or filing
with, or any permit, authorization, consent or approval of, any
Governmental Entity, (c) conflict with, result in a breach of,
constitute (with or without due notice or lapse of time or both) a
default under, result in the acceleration of obligations or
additional payments under, create in any party the right to
terminate, modify or cancel, or require any notice, consent or
waiver under, any contract or instrument to which the Company is a
party (other than contracts or instruments (i) that are terminable
at will by the other party for any reason or (ii) under which the
other party thereto can terminate the use of the Company’s
services for any reason upon notice) or by which the Company is
bound or to which its assets are subject, (d) result in the
imposition of any Security Interest upon any assets of the Company
or (e) violate any constitution, judgment, ruling, order, writ,
injunction, decree, statute, rule or regulation, or other
restriction of any government, governmental agency or court
applicable to the Company or any of its properties or
assets.
2.5
Subsidiaries
. The
Company does not have any Subsidiaries. The Company does not
control directly or indirectly or have any direct or indirect
equity participation or similar interest in any corporation,
partnership, limited liability company, joint venture, trust or
other business association or entity, except as set forth on
Section 2.5 of the Disclosure Schedule. The Company does not
have any right to acquire, directly or indirectly, any outstanding
capital stock of, or other equity interest in, any
Person.
2.6
Financial
Statements . The Company has
provided to the Buyer the Financial Statements. The Financial
Statements (i) comply as to form in all material respects with
applicable accounting requirements, (ii) were prepared in
accordance with GAAP applied on a consistent basis throughout the
periods covered thereby (except as may be indicated in the notes to
such financial statements) and (iii) fairly present the financial
position of the Company as of the dates thereof and the results of
its operations and cash flows for the periods indicated, consistent
with the books and records of the Company, except that the
unaudited interim financial statements are subject to normal and
recurring year-end adjustments which will not be material in amount
or effect and do not include footnotes.
2.7
Absence of
Certain Changes . Since the Most Recent
Balance Sheet Date, (a) there has not occurred a Company
Material Adverse Effect, and (b) except as set forth in Section 2.7
of the Disclosure Schedule, the Company has not taken any of the
actions set forth in paragraphs (a) through (v) of
Section 4.4.
2.8
Undisclosed
Liabilities . Except as and to the
extent (a) reflected and reserved against in the Most Recent
Balance Sheet, (b) set forth on Section 2.8 of the
Disclosure Schedule, or (c) incurred in the Ordinary Course of
Business after the date of the Most Recent Balance Sheet and not
material in amount, either individually or in the aggregate, the
Company
14
does not have any
liability or obligation, secured or unsecured, whether accrued,
absolute, contingent, unasserted or otherwise, which is material to
the condition (financial or otherwise) of the assets, properties or
business of the Company. For purposes of this
Section 2.8, “material” means any amount in excess
of $25,000 individually or $250,000 in the aggregate.
2.9
Tax
Matters .
(a)
The Company, its
predecessors and its past and present Subsidiaries have filed on a
timely basis with the appropriate Tax authorities all Tax Returns
that they were required to file (excluding Tax Returns of past
Subsidiaries that were required to be filed after the date such
entity was no longer a Subsidiary, unless such Tax Returns were
prepared or required to be prepared by the Company), and all such
Tax Returns were complete and accurate in all material respects
when filed. The Company has never been a member of an
affiliated group of corporations with which it has filed (or been
required to file) consolidated, combined, unitary or similar Tax
Returns, other than a group of which the Company was common
parent. The Company (and its predecessors and past and
present Subsidiaries) have paid on a timely basis all Taxes that
were due and payable whether or not shown on any Tax Return
(excluding Taxes of past Subsidiaries that were due and payable
after the date such entity was no longer a Subsidiary). The
unpaid Taxes of the Company for tax periods through the Most Recent
Balance Sheet Date do not exceed the accruals and reserves for
Taxes (excluding accruals and reserves for deferred Taxes
established to reflect timing differences between book and Tax
income) set forth on the face of the Most Recent Balance Sheet
(rather than in any notes thereto), whether as accrued Taxes or
other accrued expenses. All unpaid Taxes of the Company
attributable to periods commencing after the Most Recent Balance
Sheet Date arose in the Ordinary Course of Business. All
Taxes that the Company is or was required by Law to withhold or
collect have been duly withheld or collected and, to the extent
required, have been paid to the proper Governmental
Entity.
(b)
The Company has
made available to the Buyer complete and accurate copies of all
examination reports and statements of deficiencies assessed against
or agreed to by the Company (and its predecessors and past and
present Subsidiaries), as well as federal Income Tax Returns with
respect to all taxable periods commencing on or after December 28,
2000 (or such earlier taxable periods with respect to which the
applicable statute of limitations does not preclude the assessment
of additional Tax) (excluding Tax Returns, examination reports and
statements of deficiencies of past Subsidiaries filed, agreed to,
or assessed after the date such entity was no longer a
Subsidiary). No deficiencies for Taxes of the Company have
been claimed, proposed or assessed in writing by any taxing or
other governmental authority. The Tax Returns of the Company
have been audited by the Internal Revenue Service or the prescribed
authority in the relevant jurisdiction or are closed by the
applicable statute of limitations for all taxable years through the
taxable years specified for such Tax Returns in Section 2.9(b)
of the Disclosure Schedule. No examination or audit or, to
the knowledge of the Company, other action of or relating to any
Tax Return of the Company by any Governmental Entity is currently
in progress or, to the knowledge of the Company, threatened or
contemplated. The Company has not been informed in writing,
and has not otherwise been made aware, by any jurisdiction in which
the Company did not file a Tax Return that the jurisdiction
believes that the Company was required to file any Tax Return that
was not filed, or is subject to Tax in that
15
jurisdiction, and
there are no matters under discussion with any Governmental Entity
with respect to Taxes that are likely to result in an additional
liability of the Company for Taxes. The Company has not (nor
has any predecessor) waived any statute of limitations with respect
to Taxes or agreed to an extension of time with respect to a Tax
assessment or deficiency affecting the Company, nor has any request
been made in writing for any such extension or waiver.
(c)
The Company has
never been a United States real property holding corporation within
the meaning of Section 897(c)(2) of the Code during the
applicable period specified in Section 897(c)(l)(A)(ii) of the
Code. The Company has no actual or potential liability for
any Taxes of any person (other than the Company) under Treasury
Regulation Section 1.1502-6 (or any similar provision of law),
or as a transferee or successor, by contract, or otherwise.
The Company is not a party to or bound by a Tax indemnity, Tax
sharing, Tax allocation or similar agreement.
(d)
None of the
assets of the Company (i) is “tax-exempt use
property” or “tax-exempt bond financed property”
within the meaning of Section 168 of the Code; or
(ii) directly or indirectly secures any debt the interest on
which is tax exempt under Section 103(a) of the Code.
None of the outstanding indebtedness of the Company constitutes
indebtedness with respect to which any interest deductions have
been or may be disallowed.
(e)
There are no
adjustments under Section 481 of the Code (or any similar
adjustments under any provision of the Code or corresponding Tax
laws) that are required to be taken into account by the Company in
any period ending after the Closing Date by reason of a change in
method of accounting or other change attributable to any taxable
period ending on or before the Closing Date.
(f)
The Company has
not distributed to its shareholders or security holders stock or
securities of a controlled corporation, nor has stock or securities
of the Company been distributed, in a transaction to which Section
355 of the Code applies (i) in the two years prior to the date of
this Agreement or (ii) in a distribution that could otherwise
constitute part of a “plan” or “series of related
transactions” (within the meaning of Section 355(e) of the
Code) that includes the transactions contemplated by this
Agreement.
(g)
There are no
liens or other encumbrances with respect to Taxes upon any of the
assets or properties of the Company, other than with respect to
Taxes not yet due and payable or Taxes being contested in good
faith and for which adequate reserves have been established on the
Company’s Financial Statements.
(h)
The Stockholders
are eligible to make a Section 338(h)(10) Election with respect to
the purchase and sale of the Company Shares.
(i)
The Company (i)
has not consented at any time under former Section 341(f)(1) of the
Code to have the provisions of former Section 341(f)(2) of the Code
apply to any disposition of the assets of the Company; (ii) has not
made an election, and is not required, to treat any of its assets
as owned by another Person pursuant to the provisions of former
Section 168(f) of the Code; (iii) has not made and will not make a
consent dividend election under
16
Section 565 of
the Code; or (iv) has not made any of the foregoing elections and
is not required to apply any of the foregoing rules under any
comparable state or local Tax provision.
(j)
The Company (i)
is not a partner for Tax purposes with respect to any joint
venture, partnership, or other arrangement or contract which is
treated as a partnership for Tax purposes, (ii) does not own a
single member limited liability company which is treated as a
disregarded entity, (iii) is not and has never been a stockholder
of a “controlled foreign corporation” as defined in
Section 957 of the Code (or any similar provision of state, local
or foreign law), (iv) has never been a “personal holding
company” as defined in Section 542 of the Code (or any
similar provision of state, local or foreign law), and (v) is not a
stockholder in a “passive foreign investment company”
within the meaning of Section 1297 of the Code.
(k)
The Company has
not entered into any transaction identified as a “listed
transaction” for purposes of Treasury Regulations
§§ 1.6011-4(b)(2) or 301.6111-2(b)(2). If the
Company has entered into any transaction such that, if the
treatment claimed by it were to be disallowed, the transaction
would constitute a substantial understatement of federal income tax
within the meaning of Code Section 6662, then it believes that it
has either (x) substantial authority for the tax treatment of such
transaction or (y) disclosed on its Tax Return the relevant facts
affecting the tax treatment of such transaction.
(l)
The Company does
not have, and has not had in the past, a permanent establishment in
any foreign country, as defined in any applicable tax treaty or
convention between the United States of America and such foreign
country.
(m)
No power of
attorney with respect to any Taxes of the Company has been executed
or filed with any Governmental Entity.
(n)
Each of the
Company, its predecessors and its past and present Subsidiaries has
been either a validly electing S corporation or a valid
“qualified subchapter S subsidiary” within the meaning
of Sections 1361 and 1362 of the Code (and any comparable provision
of state, local and foreign law, in each jurisdiction which has
such a provision and in which it is or has been obligated to file
income or franchise Tax Returns), as applicable, at all times
during its existence (excluding, with respect to any
Subsidiary’s “qualified subchapter S subsidiary”
status, any period during which the entity was not a Subsidiary),
and the Company will be a valid S corporation within the meaning of
Sections 1361 and 1362 of the Code (and any comparable provision of
state, local and foreign law) up to and including the Closing
Date. None of the Company nor any qualified subchapter S
subsidiary of the Company or its predecessors has any potential
liability for any Tax under Section 1374 of the Code (or comparable
state, local or foreign provision) in connection with the sale or
deemed sale of the Company’s assets. None of the
Company nor any qualified subchapter S subsidiary of the Company or
its predecessors has ever (A) acquired assets from another
corporation in a transaction in which the Company’s Tax basis
for the acquired assets was determined, in whole or part, by
reference to the Tax basis of the acquired assets (or any other
property) in the hands of the transferor or (B) acquired the stock
of any corporation (other than the Company) which is or has been a
qualified subchapter S subsidiary.
17
(o)
Section 2.9 of
the Disclosure Schedule identifies each present and former
Subsidiary of the Company or of OGR Trust that is or was a
“qualified subchapter S subsidiary” within the meaning
of Section 1361(b)(3)(B) of the Code. Each Subsidiary so
identified was or has been a qualified subchapter S subsidiary
throughout the periods indicated on such schedule.
(p)
Union Atlantic
Insurance Company, Ltd. has validly elected under Section 953(d) to
be treated as a domestic corporation at all times since December 8,
2003 up to and including December 31, 2005.
(q)
S Corporation
Shareholders. Each of the Company Stockholders is, and has
been at all times during the period in which both (i) the Company
has been an S corporation within the meaning of Section 1361(a) of
the Code and (ii) such Company Stockholder has been a shareholder
of the Company, a valid shareholder of an S corporation within the
meaning of Section 1361(a) of the Code (and any comparable
provision of state and local Tax law in each jurisdiction in which
the Company is obligated to file income or franchise Tax
Returns).
2.10
Assets
.
(a)
Except as set
forth in Section 2.10 of the Disclosure Schedule, the Company is
the true and lawful owner of, and has good and marketable title to,
all of the assets (tangible or intangible) purported to be owned by
the Company, free and clear of all Security Interests. The
Company owns or leases all tangible assets sufficient for the
conduct of its businesses as presently conducted. Such
tangible assets, taken as a whole, have been maintained in
accordance with normal industry practice, are in functional
operating condition and repair (subject to normal wear and tear)
and are suitable for the purposes for which they are presently
used.
(b)
2.10(b) of the
Disclosure Schedule sets forth a list of all equipment, motor
vehicles and assets which have a fair market value of over $25,000
as of the date of this Agreement and which are leased by the
Company. Each item of equipment, motor vehicle and other
asset that the Company has possession of pursuant to a lease
agreement or other contractual arrangement is in such condition
that, upon its return to its lessor or owner under the applicable
lease or contract, the obligations of the Company to such lessor or
owner will have been discharged in full.
2.11
Owned Real
Property . Except as set forth
on Section 2.11 of the Disclosure Schedule, the Company does not
currently own, and has not at any time during its existence owned,
any Owned Real Property.
2.12
Real Property
Leases . Section 2.12 of
the Disclosure Schedule lists all Leases to which the Company is a
party. The Company has made available to the Buyer complete
and accurate copies of the Leases. With respect to each
Lease:
(a)
such Lease is
legal, valid, binding, enforceable and in full force and effect,
and the Company has good and clear record and marketable title to
each leasehold interest;
18
(b)
such Lease will
continue to be legal, valid, binding, enforceable and in full force
and effect immediately following the Closing in accordance with the
terms thereof as in effect immediately prior to the
Closing;
(c)
the Company has
not collaterally assigned or granted any other Security Interest in
such Lease or any interest therein; and
(d)
neither the
Company nor, to the knowledge of the Company, any other party is in
breach or violation of, or default under, any such Lease, and no
event has occurred, is pending (including the transactions
contemplated hereby) or, to the knowledge of the Company, is
threatened, which, after the giving of notice, with lapse of time,
or otherwise, would constitute a breach or default by the Company
or, to the knowledge of the Company, any other party under such
Lease.
2.13
Intellectual
Property .
(a)
Section 2.13 of
the Disclosure Schedule lists each registration or application for
registration for copyrights and each registered trademark and
service mark and any registration or application for registration
therefor and each active registered Internet domain name of the
Company. The Company does not have any patents or patent
applications.
(b)
To the knowledge
of the Company, the Company owns or has the right to use all
Intellectual Property necessary to conduct the business of the
Company as presently conducted. Each item of Company
Intellectual Property will be owned or available for use by the
Buyer immediately following the Closing on substantially identical
terms and conditions as it was immediately prior to the
Closing. The Company has taken commercially reasonable
measures to protect the proprietary nature of each item of Company
Intellectual Property. To the knowledge of the Company, no
other person or entity is infringing, violating or misappropriating
any of the Company Intellectual Property.
(c)
To the knowledge
of the Company, the use of the Company Intellectual Property by the
Company does not infringe or violate, or constitute a
misappropriation of, any Intellectual Property rights of any person
or entity. Section 2.13(c) of the Disclosure Schedule lists
each written complaint, claim or notice, or written threat thereof,
received by the Company alleging any such infringement, violation
or misappropriation since January 1, 2000. The Company
has made available to the Buyer a summary of all written
documentation in the Company’s possession relating to claims
or disputes known to the Company concerning any Company
Intellectual Property owned by the Company.
(d)
Section 2.13
of the Disclosure Schedule identifies each license or other
agreement currently in effect pursuant to which the Company has
licensed, distributed or otherwise granted any rights to any third
party with respect to, any Company Intellectual
Property.
(e)
Section 2.13
of the Disclosure Schedule identifies each item of Company
Intellectual Property that is owned by a party other than the
Company, and the license or agreement pursuant to which the Company
uses it, if any (excluding non-customized,
19
off-the-shelf
software programs licensed by the Company pursuant to “shrink
wrap” or “click-through” licenses).
2.14
Contracts
.
(a)
Section 2.14
of the Disclosure Schedule lists the following agreements (written
or oral) to which the Company is a party as of the date of this
Agreement:
(i)
any agreement (or
group of related agreements) for the lease of personal property
from or to third parties providing for lease payments in excess of
$25,000 per annum;
(ii)
any agreement (or
group of related agreements) for the purchase of products or for
the receipt of services which calls for performance over a period
of more than one year and which involves more than the sum of
$25,000.
(iii)
any agreement
concerning a partnership, joint venture or limited liability
company;
(iv)
any agreement (or
group of related agreements) under which the Company has created,
incurred, assumed or guaranteed (or may create, incur, assume or
guarantee) indebtedness for borrowed money or any capitalized lease
obligation, or under which the Company has imposed (or may impose)
a Security Interest on any of its assets, tangible or
intangible;
(v)
any agreement
with any Stockholder or their Affiliates or Barton;
(vi)
any agreement for
the acquisition of securities or substantially all of the assets of
any other person (including by merger or
consolidation);
(vii)
any agreement
concerning noncompetition or nonsolicitation by the Company, or
which otherwise restricts the ability of the Company to compete, to
which the Company is a party, and any noncompetition or
nonsolicitation agreement entered into by the Company and staff
employees of the Company;
(viii)
any employment
agreement to which the Company is a party, other than
“at-will” agreements with its employees that do not
provide for any severance, termination, change-of-control or
similar benefits;
(ix)
any agreement
under which the Company has advanced or loaned any amount currently
outstanding to any of its directors, officers and employees outside
the Ordinary Course of Business;
(x)
any agreement
involving any current or former officer, director or stockholder of
the Company or Barton or an Affiliate thereof;
(xi)
any settlement,
conciliation or similar agreement, the performance of which will
involve payment after the Closing Date of consideration in excess
of $25,000; and
20
(xii)
any agreement
under which the consequences of a default or termination would
reasonably be expected to have a Company Material Adverse
Effect.
(b)
The Company has
made available to the Buyer a complete and accurate copy of each
written agreement listed in Section 2.13 or Section 2.14
of the Disclosure Schedule. With respect to each agreement so
listed, except as set forth in Section 2.14 of the Disclosure
Schedule: (i) the agreement is legal, valid, binding and
enforceable and in full force and effect; (ii) the agreement
will continue to be legal, valid, binding and enforceable and in
full force and effect immediately following the Closing, in
accordance with the terms thereof as in effect immediately prior to
the Closing; (iii) neither the Company nor, to the knowledge
of the Company, any other party, is in breach or violation of, or
default under, any such agreement, and no event has occurred, is
pending (including the transactions contemplated hereby) or, to the
knowledge of the Company, is threatened, which, after the giving of
notice, with lapse of time, or otherwise, would constitute a breach
or default by the Company or, to the knowledge of the Company, any
other party under such agreement, and (iv) to the Company’s
knowledge, no party has repudiated any provision of the
agreement.
2.15
Accounts
Receivable . All accounts
receivable of the Company reflected on the Most Recent Balance
Sheet (other than those collected since such date) are valid
receivables and are not subject to material setoffs or
counterclaims, except as reflected in reserves on the Most Recent
Balance Sheet. All accounts receivable of the Company on the
Closing Balance Sheet will be valid receivables and are not subject
to setoffs or counterclaims, are current and collectible, and will
be collected within 120 days following the Closing Date in
accordance with their terms at their recorded amounts, except as
reflected in reserves for uncollectible accounts and deferred
revenue liabilities on the Closing Balance Sheet.
2.16
Powers of
Attorney . Other than as set
forth on Section 2.16 of the Disclosure Schedule, there are no
outstanding powers of attorney executed on behalf of the
Company.
2.17
Insurance
.
Section 2.17 of the Disclosure Schedule lists each insurance
policy (including fire, theft, casualty, comprehensive general
liability, workers compensation, business interruption,
environmental, product liability and automobile insurance policies
and bond and surety arrangements) to which the Company is a party,
all of which are in full force and effect. To the knowledge
of the Company and the Stockholders, there is no material claim
pending under any such policy as to which coverage has been
questioned, denied or disputed by the underwriter of such
policy. All premiums due and payable under all such policies
have been paid or reflected in the Financial Statements, the
Company is not liable for retroactive premiums, and the Company is
otherwise in compliance in all material respects with the terms of
such policies. The Company, nor, to the knowledge of the
Company, any other party to such policy, is in breach or default
under such policy. The Company has no knowledge of any
threatened termination of, or premium increase with respect to, any
such policy. Each such policy will continue to be enforceable
and in full force and effect immediately following the Closing in
accordance with the terms thereof as in effect immediately prior to
the Closing. The insurance policies maintained by the Company
are appropriate for the Company’s business. With
respect to matters for which the Company is self insured, the
Company maintains appropriate reserves for any claims that may not
be covered thereby.
21
2.18
Litigation
. Except as
set forth on Section 2.18 of the Disclosure Schedule, there is no
action, suit or legal, administrative or arbitration proceeding or,
to the Company’s knowledge, investigation to which the
Company is a party (either as a plaintiff or defendant) pending or,
to the knowledge of the Company, threatened before any court or
governmental agency, authority, body or arbitrator. None of
the Company Stockholders or the directors and officers of the
Company has any claim that may be brought or made against the
Company. None of the actions, suits, proceedings, hearings
and investigations set forth in Section 2.18 of the Disclosure
Schedule would reasonably be expected to result in a Company
Material Adverse Effect. There are no injunctions, judgments,
orders or decrees outstanding against the Company on the date
hereof.
2.19
Employees
.
(a)
Section 2.19(a) of the
Disclosure Schedule contains a list of all current staff employees
of the Company whose current annual rate of compensation, exclusive
of any bonus/incentives, exceeds $50,000 per year, along with the
position and the annual rate of compensation of each such
person. Except as set forth in Section 2.19(a) of the
Disclosure Schedule, no Company employee at the Vice President
level or higher has provided notice of such employee’s intent
to terminate employment with the Company and, to the knowledge of
the Company, no such employee presently plans to terminate
employment with the Company.
(b)
The Company is
not now and has not been a party to or bound by any collective
bargaining or similar agreement, nor during the past five years has
the Company experienced any strikes, slowdowns, work stoppages,
grievances, lockouts, claims of unfair labor practices or other
collective bargaining disputes and, to the knowledge of the
Company, no such strikes, slowdowns, work stoppages, grievances,
lockouts, claims of unfair labor practices or other collective
bargaining disputes are threatened. There are no labor unions
or other organizations, either currently or within the past five
years, representing, purporting to represent or, to the knowledge
of the Company, attempting to represent any employees of the
Company.
(c)
The Company is in
compliance with all applicable laws relating to the hiring and
employment of employees, including without limitation, laws
relating to wrongful discharge, discrimination, leaves of absence,
wages, hours, collective bargaining and fair labor
standards.
(d)
The Company has
properly classified all of its service providers as either
employees or independent contractors. The Company has
withheld and paid to the appropriate governmental authority all
amounts required to be withheld from compensation paid to its
employees and is not liable for any arrears of taxes, penalties or
other sums for failure to withhold and pay applicable taxes.
There is no claim against the Company with respect to payment of
wages, salary or overtime pay that has been asserted or is now
pending or, to the Company’s knowledge, threatened by any
current or former service providers of the Company, nor, to the
Company’s knowledge, do any circumstances exist which would
reasonably be expected to result in any such claim.
(e)
In the three
years prior to the date hereof, the Company has not effectuated
(i) a “plant closing” (as defined in the Worker
Adjustment and Retraining Notification Act (the
22
“ WARN
Act ”) or any similar state, local or foreign Law)
affecting any site of employment or one or more facilities or
operating units within any site of employment or facility of the
Company, or (ii) a “mass layoff” (as defined in
the WARN Act, or any similar state, local or foreign law) affecting
any site of employment or facility of the Company. The
Company has no material liabilities, whether contingent or
absolute, relating to workers’ compensation benefits that are
not fully insured against by a bona fide third-party insurance
carrier to the extent required by applicable law.
(f)
Section 2.19 (f)
of the Disclosure Schedule sets forth any and all indebtedness in
excess of ten thousand U.S. dollars (US$10,000) owed to the Company
by any current or former employee, consultant or director of the
Company.
2.20
Employee
Benefits .
(a)
Section 2.20 of
the Disclosure Schedule contains a complete and accurate list of
all Company Plans. Complete and accurate copies of
(i) all Company Plans which have been reduced to writing
(including all amendments thereto), (ii) written summaries of
all unwritten Company Plans, (iii) all related current trust
agreements, insurance contracts and summary plan descriptions and
material written employee communications distributed generally to
employees, regarding such Company Plans (including, in each case,
any material modifications thereof), (iv) all annual reports
filed on IRS Form 5500, 5500C or 5500R (including all exhibits and
attachments thereto) for each Company Plan, (v) if a Company Plan
is intended to qualify under Section 401(a) of the Code, the most
recent IRS opinion letter for a prototype plan, and (vi) all
material communications with any governmental entity or agency,
including, without limitation, the U.S. Department of Labor, the
IRS and the Pension Benefit Guaranty Corporation, have been made
available to the Buyer. The Company has not made any plan or
commitment to create any new or additional Company Plan or to
modify any existing Company Plan that would increase the
compensation or benefits provided to any current or former
employee, consultant or director of the Company or the spouses,
beneficiaries or other dependents thereof.
(b)
Each of the
Company and its ERISA Affiliates has, in all material respects, (i)
met its obligations with respect to each Company Plan, (ii) made
or, to the extent not yet due, accrued on its consolidated
financial statements to the extent required by GAAP, all required
contributions (including all employer contributions and employee
salary reduction contributions) thereto, and (iii) paid all
premiums and expenses to or in respect of such Company Plan The
Company, each ERISA Affiliate and each Company Plan are in
compliance in all material respects with the applicable provisions
of ERISA, the Code and foreign law applicable to any Company Plan
and any regulations thereunder (including without limitation
Section 4980B of the Code, Subtitle K, Chapter 100 of the Code and
Sections 601 through 608 and Section 701 et seq. of ERISA).
All filings and reports as to each Company Plan required to have
been submitted to the IRS or to the United States Department of
Labor have been duly submitted. No Company Plan or related
trust holds assets that include securities issued by the Company or
any ERISA Affiliate.
(c)
With respect to
each Company Plan: (i) no breaches of fiduciary duty or other
failure to act or comply in connection with the administration or
investment of the assets of
23
a Company Plan in
connection with which the Company could reasonably be expected to
incur a material liability have occurred; (ii) no non-exempt
prohibited transaction within the meaning of Section 406 of ERISA
or Section 4975 of the Code has occurred that could reasonably be
expected to result in a material liability to the Company; and
(iii) no lien has been imposed on the assets of the Company or the
assets of any Company Plan under the Code, ERISA or any comparable
foreign law. The Company has not failed to distribute any
required reports or descriptions to any Company Plan participants
(including without limitation any summary annual reports or summary
plan descriptions).
(d)
Except as set
forth in Section 2.20(d) of the Disclosure Schedule, there are no
Legal Proceedings (including without limitation any audits or
investigation by the IRS, the U.S. Department of Labor, the Pension
Benefit Guaranty Corporation or any other federal, state or foreign
Governmental Authority), except claims for benefits payable in the
normal operation of the Company Plans and proceedings with respect
to qualified domestic relations orders, pending or, to the
knowledge of the Company, threatened, against, by, on behalf of or
involving any Company Plan, the Company with respect to any Company
Plan, or the assets, fiduciaries or administrators thereof or
asserting any rights or claims to benefits under any Company Plan
that could give rise to any material liability.
(e)
Each Company Plan
that is intended to be qualified under Section 401(a) of the Code
is a prototype plan for which the prototype plan sponsor has
received a favorable opinion letter from the IRS on which the
Company is entitled to rely and, except as set forth in Section
2.20(e) of the Disclosure Schedule, (i) no such plan has been
modified or amended such that the plan would be considered an
individually designed plan, (ii) no such opinion letter has been
revoked and revocation has not been threatened, (iii) to the
knowledge of the Company, no event or circumstance exists that has
adversely affected or is likely to adversely affect such opinion
letter, (iv) no such Company Plan has been amended since the date
of its most recent opinion letter in any respect, and (v) no act or
omission has occurred, that would reasonably be expected to
adversely affect the qualification of such Company Plan or
materially increase its costs. Each Company Plan which is
required to satisfy Section 401(k)(3) or Section 401(m)(2) of the
Code has been tested for compliance with, and satisfies the
requirements of Section 401(k)(3) and Section 401(m)(2) of the Code
for each plan year ending prior to the Closing Date. Each
Company Plan that is intended to qualify under any law of any
foreign jurisdiction has received any required approval of a
government authority of a foreign jurisdiction which approval has
not been revoked and, to the knowledge of the Company, no event or
circumstance exists that has adversely affected or is likely to
adversely affect such qualification or approval.
(f)
No Company Plan
is, and neither the Company nor any ERISA Affiliate maintains,
contributes to, or has ever maintained or been obligated to
contribute to an Employee Benefit Plan subject to Section 412 of
the Code, Title IV of ERISA or comparable funding obligations
imposed under the laws of any foreign jurisdiction.
(g)
At no time has
the Company or any ERISA Affiliate been obligated to contribute to
any “multiemployer plan” (as defined in Section
4001(a)(3) of ERISA) or “multiple employer plan” (as
defined in Section 413(c) of the Code).
24
(h)
Except as set
forth on Section 2.20(h) of the Disclosure Schedule, the Company
has no obligations under any Company Plan or otherwise to provide
benefits after termination of employment or service to any current
or former employees, consultants or directors of the Company (or to
any spouse, dependent or beneficiary of any of the foregoing),
including but not limited to obligations to provide health,
accident, disability or life insurance coverage or deferred
compensation, but excluding continuation of health coverage
required to be continued under Section 4980B of the Code or
other applicable law and insurance conversion privileges provided
under state law. There has been no written communication to
any current or former employee, consultant, director or any retiree
of the Company, or the spouses, dependents or beneficiaries of any
of the foregoing, that would reasonably be expected to promise or
guarantee any such health, accident, disability or life insurance
coverage or deferred compensation.
(i)
No act or
omission has occurred and no condition exists with respect to any
Company Plan that would subject the Company to (i) any material
fine, penalty, tax or liability of any kind imposed under ERISA or
the Code for failure to comply with any legal requirements
pertaining to any Company Plan, or (ii) any contractual
indemnification or contribution obligation protecting any
fiduciary, insurer or service provider with respect to any Company
Plan.
(i)
No Company Plan
is currently funded by, associated with or related to a
“voluntary employee’s beneficiary association”
within the meaning of Section 501(c)(9) of the
Code.
(ii)
Each Company Plan
is amendable and terminable unilaterally by the Company at any time
without material penalty to the Company or such Company Plan as a
result thereof (other than for benefits accrued through the date of
termination or amendment and reasonable administrative expenses
related thereto) and no Company Plan, plan documentation or
agreement, summary plan description or other written communication
distributed generally to employees by its terms prohibits the
Company from amending or terminating any such Company
Plan.
(j)
Except as set
forth in Section 2.20(j) of the Disclosure Schedule, neither the
execution and delivery of this Agreement, nor the consummation of
the transactions contemplated hereby, either alone or in
combination with another event (whether contingent or otherwise)
will (i) entitle any current or former employee, consultant or
director of the Company or any group of such employees, consultants
or directors to any payment or benefit; (ii) increase the amount of
compensation or benefits due to any such employee, consultant or
director; or (iii) accelerate the vesting, funding or time of
payment of any compensation, equity award or other
benefit.
(k)
Neither the
execution and delivery of this Agreement, nor the consummation of
the transactions contemplated hereby, either alone or in
combination with another event (whether contingent or otherwise)
will result in any “parachute payment” under Code
Section 280G (whether or not such payment is considered to be
reasonable compensation for services rendered).
25
(l)
Each of the
Company and the ERISA Affiliates is in compliance in all material
respects with (i) the requirements of the applicable health care
continuation and notice provisions of the Consolidated Omnibus
Budget Reconciliation Act of 1985, as amended, and the regulations
(including proposed regulations) thereunder and any similar state
law, and (ii) the applicable requirements of the Health Insurance
Portability and Accountability Act of 1996, as amended, and the
regulations (including the proposed regulations)
thereunder.
(m)
With respect to
each Company Plan providing compensation or benefits to any
employee or former employee of the Company (or any dependent or
beneficiary thereof) which is subject to the laws of any
jurisdiction outside of the United States (the “Foreign
Plans”): (i) such Foreign Plan has been maintained in all
material respects in accordance with all applicable requirements
and all applicable laws, (ii) if intended to qualify for special
tax treatment, such Foreign Plan meets all requirements for such
treatment, (iii) if intended or required to be funded and/or
book-reserved, such Foreign Plan is fully funded and/or book
reserved, as appropriate, based upon reasonable actuarial
assumptions, and (iv) no material liability exists or reasonably
could be imposed upon the assets of the Company by reason of such
Foreign Plan.
(n)
Section 2.20(n)
of the Disclosure Schedule sets forth the policy of the Company
with respect to accrued vacation, accrued sick time and earned time
off and the amount of such liabilities as of the Most Recent
Balance Sheet Date.
(o)
To the
Company’s knowledge, each Company Plan that is a nonqualified
deferred compensation plan subject to Code Section 409A has been
operated and administered in good-faith compliance with Code
Section 409A from the period beginning January 1, 2005 through the
date hereof.
2.21
Environmental
Matters .
(a)
The Company has
complied in all material respects with all applicable Environmental
Laws. There is no pending or, to the knowledge of the Company
or the Stockholders, threatened civil or criminal litigation,
written notice of violation, formal administrative proceeding, or
investigation, inquiry or information request by any Governmental
Entity, relating to any Environmental Law involving the
Company.
(b)
The Company is
not a party to or bound by any court order, administrative order,
consent order or other agreement between the Company and any
Governmental Entity entered into in connection with any legal
obligation or liability arising under any Environmental
Law.
(c)
The Company is
not aware of any material environmental liability of any solid or
hazardous waste transporter or treatment, storage or disposal
facility involving the transportation, treatment, storage or
disposal of solid or hazardous wastes of the Company.
2.22
Legal
Compliance . The Company and each
of its predecessors has complied with each applicable law
(including rules, regulations, codes, plans, injunctions,
judgments, orders, decrees and rulings thereunder) of any federal,
state, local or foreign government, or any
26
Governmental
Entity. During the five years preceding the date hereof, the
Company has not received any written notice or communication from
any Governmental Entity alleging noncompliance with any applicable
law, rule or regulation.
2.23
Existing
Customers and Suppliers . Except as set forth
on Section 2.23 of the Disclosure Schedule, neither the
Company nor any of the Stockholders has reason to believe that any
customer or supplier of the Company will not continue to do
business with the Buyer after the Closing Date as a result of this
transaction.
2.24
Permits
.
Section 2.24 of the Disclosure Schedule sets forth a list of
all Permits issued to and held by the Company. Such listed
Permits are the only Permits that are required for the Company to
conduct its business as presently conducted. Each such Permit
is in full force and effect, the Company is in compliance with the
terms of each such Permit, and, to the knowledge of the Company, no
suspension or cancellation of such Permit is threatened. The
Company does not have any knowledge of any existing condition that
would cause any such Permit to fail to continue in full force and
effect immediately following the Closing.
2.25
Certain
Business Relationships With Affiliates . Except as set forth
in Section 2.25 of the Disclosure Schedule, no Affiliate, officer
or director of the Company or Barton (a) owns any property or
right, tangible or intangible, which is used in the business of the
Company, or (b) owes any money to, or is owed any money by, the
Company. Section 2.25 of the Disclosure Schedule describes
any transactions or relationships between the Company and any
Affiliate of the Company or Barton which occurred or have existed
since the beginning of the time period covered by the Financial
Statements.
2.26
Books and
Records . The minute books and
other similar records of the Company contain correct complete and
accurate records in all material respects of all actions taken at
any meetings of the Company’s stockholders, Board of
Directors or any committee thereof and of all written consents
executed in lieu of the holding of any such meeting.
Section 2.26 of the Disclosure Schedule contains a list of all
bank accounts and safe deposit boxes of the Company and the names
of persons having signature authority with respect thereto or
access thereto.
2.27
Brokers’
Fees . Except as set forth
in Section 2.27 of the Disclosure Schedule, the Company does not
have any liability to pay any fees or commissions to any broker,
finder or agent with respect to th
|